Back to Capital World Investors Capital World Investors

NVCR

Showing 6 of 27 quarters

Position history for Capital World InvestorsCapital World Investors's holdings in NovoCure Limited

No. Capital World Investors exited its NVCR (NovoCure) position in Q4 2025. Its Q3 2025 13F listed 2,000,000 shares worth $25.8M. Capital World Investors already held NVCR in its Q2 2019 13F, the earliest on record, and held it in 26 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$67.3M

Total Shares Change

-4.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$12.93
0
2025-Q3
Decreased
2M
-68.7%
$25.8M0.0%$12.92
0
2025-Q2
Increased
6.4M
+22.4%
$113.6M0.0%$17.80
36
2025-Q1
Increased
5.2M
+8.3%
$92.9M0.0%$17.82
32
2024-Q4
Increased
4.8M
+11.8%
$143.5M0.0%$29.80
34
2024-Q3
Increased
4.3M
+86.7%
$67.3M0.0%$15.63
46

Other major holders of NVCR: FMR LLC, Baillie Gifford & Co., Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used